CRISPR Therapeutics to Participate in B. Riley Securities’ 3rd Annual Oncology Conference

Wednesday, January 11, 2023 1 min read

Key Takeaway: CRISPR Therapeutics to Participate in B. Riley Securities’ 3rd Annual Oncology Conference

Full Press Release Details

CRISPR Therapeutics to Participate in B. Riley Securities’ 3rd Annual Oncology Conference.